Shire
Global Innovator in Specialty Biopharmaceuticals.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD9.1b (Public information from Dec 2018)
Dublin County Dublin (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenues | - | - | 1.0m | 2.0m | 2.0m |
| % growth | - | - | - | 100 % | - |
| EBITDA | - | - | 1.0m | 2.0m | 2.0m |
| % EBITDA margin | - | - | 100 % | 100 % | 100 % |
| R&D budget | 825m | 1.3b | 1.4b | - | - |
| R&D % of revenue | - | - | 143100 % | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
* | $5.9b Valuation: $5.9b 5363.6x EV/LTM Revenues 5363.6x EV/LTM EBITDA | Acquisition | |
| Total Funding | - | ||
Related Content
Recent News about Shire
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Shire
Edit
ACQUISITION by Shire Aug 2015
ACQUISITION by JCR Pharmaceuticals Mar 2020
ACQUISITION by Shire Apr 2007
ACQUISITION by Allergan Jul 2015
ACQUISITION by Shire May 2014
ACQUISITION by Shire Nov 2013
ACQUISITION by Shire Aug 2010
ACQUISITION by Shire Feb 2015